Hereditary cancer and cancer genetics
Hereditary cancer and cancer genetics
Referral for cancer genetics consultation: a review and compilation of risk assessment criteria
Heather Hampel, K Sweet, J A Westman1, K Offit and C Eng.
Journal of Medical Genetics. Volume 41, Issue
2: p. 81-91, February 2004.
TGFBR1*6A
and cancer risk: A meta-analysis of seven case-control studies
Virginia G. Kaklamani, Nanjiang Hou, Yiansong Bian, Jennifer Reich,
Kenneth Offit, Loren S. Michel, W.S. Rubinstein, Alfred Rademaker,
Boris Pasche.
Journal of Clinical Oncology. Volume 21, Issue
17: p. 3236-3243, September 2003.
Frequency
of CHEK2*1100delC in New York breast cancer cases and controls
Kenneth Offit, Heather Pierce, Tomas Kirchhoff,
Prema Kolachana, Beth Rapaport, Peter Gregersen,
Steven Johnson, Orit Yossepowitch, Helen Huang,
Jaya Satagopan, Mark Robson, Lauren Scheuer, Khedoudja
Nafa, Nathan Ellis.
BMC Medical Genetics. Volume 4, Issue 1: p.1,
January 2003.
Breast
cancer genetics in African Americans
Olufunmilayo I. Olopade, M.B., B.S., James D. Fackenthal, Ph.D.,
Georgia Dunston, Ph.D., Michael A. Tainsky, MD, Ph.D., Francis Collins,
M.D., Ph.D., Carolyn Whitfield-Broome, Ph.D. Cancer. Volume
97, Issue S1: p. 236-245, December 2002.
A
CHEK2 genetic variant contributing to a substantial fraction of
familial breast cancer
Pia Vahteristo, Jirina Bartkova, Hannaleena Eerola, Kirsi Syrjäkoski,
Salla Ojala, Outi Kilpivaara, Anitta Tamminen, Juha Kononen, Kristiina
Aittomäki, Päivi Heikkilä, Kaija Holli, Carl Blomqvist,
Jiri Bartek, Olli-P. Kallioniemi, and Heli Nevanlinna.
American Journal of Human Genetics.
Volume 71, Issue 2: p. 432-438, August 2002.
Low-Penetrance
susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1
or BRCA2 mutations
The CHEK2-Breast Cancer Consortium. Nature Genetics.
Volume 1: p. 55-59, May 2002.